English
简体中文
Total: £ 56.28
Published Date: 2024-11-14 | Pages: 74 | Tables: 106 | Pharma & Healthcare
Burosumab , a fully human IgG1 monoclonal antibody directed at fibroblast growth factor 23 (FGF23), is indicated for the treatment of X-linked hypophosphatemia (XLH), a condition associated with excessive FGF23 production.
The global Burosumab market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Burosumab is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Burosumab is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Burosumab is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Burosumab include Ultragenyx and Kyowa Kirin etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Burosumab, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Burosumab, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Burosumab, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Burosumab sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Burosumab market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Burosumab sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Segment by Type
10mg/mL
20mg/mL
30mg/mL
Segment by Application
Minor Patients Over 1 Year Old
Adult Patients
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Burosumab in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Burosumab manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Burosumab sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Burosumab Product Introduction
1.2 Market by Type
1.2.1 Global Burosumab Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 10mg/mL
1.2.3 20mg/mL
1.2.4 30mg/mL
1.3 Market by Application
1.3.1 Global Burosumab Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Minor Patients Over 1 Year Old
1.3.3 Adult Patients
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Burosumab Sales Estimates and Forecasts 2019-2030
2.2 Global Burosumab Revenue by Region
2.2.1 Global Burosumab Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Burosumab Revenue by Region (2019-2024)
2.2.3 Global Burosumab Revenue by Region (2025-2030)
2.2.4 Global Burosumab Revenue Market Share by Region (2019-2030)
2.3 Global Burosumab Sales Estimates and Forecasts 2019-2030
2.4 Global Burosumab Sales by Region
2.4.1 Global Burosumab Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Burosumab Sales by Region (2019-2024)
2.4.3 Global Burosumab Sales by Region (2025-2030)
2.4.4 Global Burosumab Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Burosumab Sales by Manufacturers
3.1.1 Global Burosumab Sales by Manufacturers (2019-2024)
3.1.2 Global Burosumab Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Burosumab in 2023
3.2 Global Burosumab Revenue by Manufacturers
3.2.1 Global Burosumab Revenue by Manufacturers (2019-2024)
3.2.2 Global Burosumab Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Burosumab Revenue in 2023
3.3 Global Key Players of Burosumab, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Burosumab Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Burosumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Burosumab, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Burosumab, Product Offered and Application
3.8 Global Key Manufacturers of Burosumab, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Burosumab Sales by Type
4.1.1 Global Burosumab Historical Sales by Type (2019-2024)
4.1.2 Global Burosumab Forecasted Sales by Type (2025-2030)
4.1.3 Global Burosumab Sales Market Share by Type (2019-2030)
4.2 Global Burosumab Revenue by Type
4.2.1 Global Burosumab Historical Revenue by Type (2019-2024)
4.2.2 Global Burosumab Forecasted Revenue by Type (2025-2030)
4.2.3 Global Burosumab Revenue Market Share by Type (2019-2030)
4.3 Global Burosumab Price by Type
4.3.1 Global Burosumab Price by Type (2019-2024)
4.3.2 Global Burosumab Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Burosumab Sales by Application
5.1.1 Global Burosumab Historical Sales by Application (2019-2024)
5.1.2 Global Burosumab Forecasted Sales by Application (2025-2030)
5.1.3 Global Burosumab Sales Market Share by Application (2019-2030)
5.2 Global Burosumab Revenue by Application
5.2.1 Global Burosumab Historical Revenue by Application (2019-2024)
5.2.2 Global Burosumab Forecasted Revenue by Application (2025-2030)
5.2.3 Global Burosumab Revenue Market Share by Application (2019-2030)
5.3 Global Burosumab Price by Application
5.3.1 Global Burosumab Price by Application (2019-2024)
5.3.2 Global Burosumab Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Burosumab Market Size by Type
6.1.1 US & Canada Burosumab Sales by Type (2019-2030)
6.1.2 US & Canada Burosumab Revenue by Type (2019-2030)
6.2 US & Canada Burosumab Market Size by Application
6.2.1 US & Canada Burosumab Sales by Application (2019-2030)
6.2.2 US & Canada Burosumab Revenue by Application (2019-2030)
6.3 US & Canada Burosumab Market Size by Country
6.3.1 US & Canada Burosumab Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Burosumab Sales by Country (2019-2030)
6.3.3 US & Canada Burosumab Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Burosumab Market Size by Type
7.1.1 Europe Burosumab Sales by Type (2019-2030)
7.1.2 Europe Burosumab Revenue by Type (2019-2030)
7.2 Europe Burosumab Market Size by Application
7.2.1 Europe Burosumab Sales by Application (2019-2030)
7.2.2 Europe Burosumab Revenue by Application (2019-2030)
7.3 Europe Burosumab Market Size by Country
7.3.1 Europe Burosumab Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Burosumab Sales by Country (2019-2030)
7.3.3 Europe Burosumab Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Burosumab Market Size
8.1.1 China Burosumab Sales (2019-2030)
8.1.2 China Burosumab Revenue (2019-2030)
8.2 China Burosumab Market Size by Application
8.2.1 China Burosumab Sales by Application (2019-2030)
8.2.2 China Burosumab Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Burosumab Market Size by Type
9.1.1 Asia Burosumab Sales by Type (2019-2030)
9.1.2 Asia Burosumab Revenue by Type (2019-2030)
9.2 Asia Burosumab Market Size by Application
9.2.1 Asia Burosumab Sales by Application (2019-2030)
9.2.2 Asia Burosumab Revenue by Application (2019-2030)
9.3 Asia Burosumab Sales by Region
9.3.1 Asia Burosumab Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Burosumab Revenue by Region (2019-2030)
9.3.3 Asia Burosumab Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Burosumab Market Size by Type
10.1.1 Middle East, Africa and Latin America Burosumab Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Burosumab Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Burosumab Market Size by Application
10.2.1 Middle East, Africa and Latin America Burosumab Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Burosumab Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Burosumab Sales by Country
10.3.1 Middle East, Africa and Latin America Burosumab Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Burosumab Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Burosumab Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Ultragenyx
11.1.1 Ultragenyx Company Information
11.1.2 Ultragenyx Overview
11.1.3 Ultragenyx Burosumab Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Ultragenyx Burosumab Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Ultragenyx Recent Developments
11.2 Kyowa Kirin
11.2.1 Kyowa Kirin Company Information
11.2.2 Kyowa Kirin Overview
11.2.3 Kyowa Kirin Burosumab Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Kyowa Kirin Burosumab Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Kyowa Kirin Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Burosumab Industry Chain Analysis
12.2 Burosumab Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Burosumab Production Mode & Process
12.4 Burosumab Sales and Marketing
12.4.1 Burosumab Sales Channels
12.4.2 Burosumab Distributors
12.5 Burosumab Customers
13 Market Dynamics
13.1 Burosumab Industry Trends
13.2 Burosumab Market Drivers
13.3 Burosumab Market Challenges
13.4 Burosumab Market Restraints
14 Key Findings in The Global Burosumab Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Burosumab Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of 10mg/mL
Table 3. Major Manufacturers of 20mg/mL
Table 4. Major Manufacturers of 30mg/mL
Table 5. Global Burosumab Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Burosumab Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 7. Global Burosumab Revenue by Region (2019-2024) & (US$ Million)
Table 8. Global Burosumab Revenue by Region (2025-2030) & (US$ Million)
Table 9. Global Burosumab Revenue Market Share by Region (2019-2024)
Table 10. Global Burosumab Revenue Market Share by Region (2025-2030)
Table 11. Global Burosumab Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 12. Global Burosumab Sales by Region (2019-2024) & (K Units)
Table 13. Global Burosumab Sales by Region (2025-2030) & (K Units)
Table 14. Global Burosumab Sales Market Share by Region (2019-2024)
Table 15. Global Burosumab Sales Market Share by Region (2025-2030)
Table 16. Global Burosumab Sales by Manufacturers (2019-2024) & (K Units)
Table 17. Global Burosumab Sales Share by Manufacturers (2019-2024)
Table 18. Global Burosumab Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 19. Global Burosumab Revenue Share by Manufacturers (2019-2024)
Table 20. Global Key Players of Burosumab, Industry Ranking, 2022 VS 2023 VS 2024
Table 21. Burosumab Price by Manufacturers 2019-2024 (US$/Unit)
Table 22. Global Burosumab Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Burosumab by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Burosumab as of 2023)
Table 24. Global Key Manufacturers of Burosumab, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Burosumab, Product Offered and Application
Table 26. Global Key Manufacturers of Burosumab, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Burosumab Sales by Type (2019-2024) & (K Units)
Table 29. Global Burosumab Sales by Type (2025-2030) & (K Units)
Table 30. Global Burosumab Sales Share by Type (2019-2024)
Table 31. Global Burosumab Sales Share by Type (2025-2030)
Table 32. Global Burosumab Revenue by Type (2019-2024) & (US$ Million)
Table 33. Global Burosumab Revenue by Type (2025-2030) & (US$ Million)
Table 34. Global Burosumab Revenue Share by Type (2019-2024)
Table 35. Global Burosumab Revenue Share by Type (2025-2030)
Table 36. Burosumab Price by Type (2019-2024) & (US$/Unit)
Table 37. Global Burosumab Price Forecast by Type (2025-2030) & (US$/Unit)
Table 38. Global Burosumab Sales by Application (2019-2024) & (K Units)
Table 39. Global Burosumab Sales by Application (2025-2030) & (K Units)
Table 40. Global Burosumab Sales Share by Application (2019-2024)
Table 41. Global Burosumab Sales Share by Application (2025-2030)
Table 42. Global Burosumab Revenue by Application (2019-2024) & (US$ Million)
Table 43. Global Burosumab Revenue by Application (2025-2030) & (US$ Million)
Table 44. Global Burosumab Revenue Share by Application (2019-2024)
Table 45. Global Burosumab Revenue Share by Application (2025-2030)
Table 46. Burosumab Price by Application (2019-2024) & (US$/Unit)
Table 47. Global Burosumab Price Forecast by Application (2025-2030) & (US$/Unit)
Table 48. US & Canada Burosumab Sales by Type (2019-2024) & (K Units)
Table 49. US & Canada Burosumab Sales by Type (2025-2030) & (K Units)
Table 50. US & Canada Burosumab Revenue by Type (2019-2024) & (US$ Million)
Table 51. US & Canada Burosumab Revenue by Type (2025-2030) & (US$ Million)
Table 52. US & Canada Burosumab Sales by Application (2019-2024) & (K Units)
Table 53. US & Canada Burosumab Sales by Application (2025-2030) & (K Units)
Table 54. US & Canada Burosumab Revenue by Application (2019-2024) & (US$ Million)
Table 55. US & Canada Burosumab Revenue by Application (2025-2030) & (US$ Million)
Table 56. US & Canada Burosumab Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 57. US & Canada Burosumab Revenue by Country (2019-2024) & (US$ Million)
Table 58. US & Canada Burosumab Revenue by Country (2025-2030) & (US$ Million)
Table 59. US & Canada Burosumab Sales by Country (2019-2024) & (K Units)
Table 60. US & Canada Burosumab Sales by Country (2025-2030) & (K Units)
Table 61. Europe Burosumab Sales by Type (2019-2024) & (K Units)
Table 62. Europe Burosumab Sales by Type (2025-2030) & (K Units)
Table 63. Europe Burosumab Revenue by Type (2019-2024) & (US$ Million)
Table 64. Europe Burosumab Revenue by Type (2025-2030) & (US$ Million)
Table 65. Europe Burosumab Sales by Application (2019-2024) & (K Units)
Table 66. Europe Burosumab Sales by Application (2025-2030) & (K Units)
Table 67. Europe Burosumab Revenue by Application (2019-2024) & (US$ Million)
Table 68. Europe Burosumab Revenue by Application (2025-2030) & (US$ Million)
Table 69. Europe Burosumab Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 70. Europe Burosumab Revenue by Country (2019-2024) & (US$ Million)
Table 71. Europe Burosumab Revenue by Country (2025-2030) & (US$ Million)
Table 72. Europe Burosumab Sales by Country (2019-2024) & (K Units)
Table 73. Europe Burosumab Sales by Country (2025-2030) & (K Units)
Table 74. China Burosumab Sales by Type (2019-2024) & (K Units)
Table 75. China Burosumab Sales by Type (2025-2030) & (K Units)
Table 76. China Burosumab Revenue by Type (2019-2024) & (US$ Million)
Table 77. China Burosumab Revenue by Type (2025-2030) & (US$ Million)
Table 78. China Burosumab Sales by Application (2019-2024) & (K Units)
Table 79. China Burosumab Sales by Application (2025-2030) & (K Units)
Table 80. China Burosumab Revenue by Application (2019-2024) & (US$ Million)
Table 81. China Burosumab Revenue by Application (2025-2030) & (US$ Million)
Table 82. Asia Burosumab Sales by Type (2019-2024) & (K Units)
Table 83. Asia Burosumab Sales by Type (2025-2030) & (K Units)
Table 84. Asia Burosumab Revenue by Type (2019-2024) & (US$ Million)
Table 85. Asia Burosumab Revenue by Type (2025-2030) & (US$ Million)
Table 86. Asia Burosumab Sales by Application (2019-2024) & (K Units)
Table 87. Asia Burosumab Sales by Application (2025-2030) & (K Units)
Table 88. Asia Burosumab Revenue by Application (2019-2024) & (US$ Million)
Table 89. Asia Burosumab Revenue by Application (2025-2030) & (US$ Million)
Table 90. Asia Burosumab Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 91. Asia Burosumab Revenue by Region (2019-2024) & (US$ Million)
Table 92. Asia Burosumab Revenue by Region (2025-2030) & (US$ Million)
Table 93. Asia Burosumab Sales by Region (2019-2024) & (K Units)
Table 94. Asia Burosumab Sales by Region (2025-2030) & (K Units)
Table 95. Middle East, Africa and Latin America Burosumab Sales by Type (2019-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Burosumab Sales by Type (2025-2030) & (K Units)
Table 97. Middle East, Africa and Latin America Burosumab Revenue by Type (2019-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Burosumab Revenue by Type (2025-2030) & (US$ Million)
Table 99. Middle East, Africa and Latin America Burosumab Sales by Application (2019-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Burosumab Sales by Application (2025-2030) & (K Units)
Table 101. Middle East, Africa and Latin America Burosumab Revenue by Application (2019-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Burosumab Revenue by Application (2025-2030) & (US$ Million)
Table 103. Middle East, Africa and Latin America Burosumab Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 104. Middle East, Africa and Latin America Burosumab Revenue by Country (2019-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Burosumab Revenue by Country (2025-2030) & (US$ Million)
Table 106. Middle East, Africa and Latin America Burosumab Sales by Country (2019-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Burosumab Sales by Country (2025-2030) & (K Units)
Table 108. Ultragenyx Company Information
Table 109. Ultragenyx Description and Major Businesses
Table 110. Ultragenyx Burosumab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. Ultragenyx Burosumab Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Ultragenyx Recent Developments
Table 113. Kyowa Kirin Company Information
Table 114. Kyowa Kirin Description and Major Businesses
Table 115. Kyowa Kirin Burosumab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Kyowa Kirin Burosumab Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Kyowa Kirin Recent Developments
Table 118. Key Raw Materials Lists
Table 119. Raw Materials Key Suppliers Lists
Table 120. Burosumab Distributors List
Table 121. Burosumab Customers List
Table 122. Burosumab Market Trends
Table 123. Burosumab Market Drivers
Table 124. Burosumab Market Challenges
Table 125. Burosumab Market Restraints
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Burosumab Product Picture
Figure 2. Global Burosumab Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Burosumab Market Share by Type in 2023 & 2030
Figure 4. 10mg/mL Product Picture
Figure 5. 20mg/mL Product Picture
Figure 6. 30mg/mL Product Picture
Figure 7. Global Burosumab Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 8. Global Burosumab Market Share by Application in 2023 & 2030
Figure 9. Minor Patients Over 1 Year Old
Figure 10. Adult Patients
Figure 11. Burosumab Report Years Considered
Figure 12. Global Burosumab Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Burosumab Revenue 2019-2030 (US$ Million)
Figure 14. Global Burosumab Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 15. Global Burosumab Revenue Market Share by Region (2019-2030)
Figure 16. Global Burosumab Sales 2019-2030 ((K Units)
Figure 17. Global Burosumab Sales Market Share by Region (2019-2030)
Figure 18. US & Canada Burosumab Sales YoY (2019-2030) & (K Units)
Figure 19. US & Canada Burosumab Revenue YoY (2019-2030) & (US$ Million)
Figure 20. Europe Burosumab Sales YoY (2019-2030) & (K Units)
Figure 21. Europe Burosumab Revenue YoY (2019-2030) & (US$ Million)
Figure 22. China Burosumab Sales YoY (2019-2030) & (K Units)
Figure 23. China Burosumab Revenue YoY (2019-2030) & (US$ Million)
Figure 24. Asia (excluding China) Burosumab Sales YoY (2019-2030) & (K Units)
Figure 25. Asia (excluding China) Burosumab Revenue YoY (2019-2030) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Burosumab Sales YoY (2019-2030) & (K Units)
Figure 27. Middle East, Africa and Latin America Burosumab Revenue YoY (2019-2030) & (US$ Million)
Figure 28. The Burosumab Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 29. The Top 5 and 10 Largest Manufacturers of Burosumab in the World: Market Share by Burosumab Revenue in 2023
Figure 30. Global Burosumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 31. Global Burosumab Sales Market Share by Type (2019-2030)
Figure 32. Global Burosumab Revenue Market Share by Type (2019-2030)
Figure 33. Global Burosumab Sales Market Share by Application (2019-2030)
Figure 34. Global Burosumab Revenue Market Share by Application (2019-2030)
Figure 35. US & Canada Burosumab Sales Market Share by Type (2019-2030)
Figure 36. US & Canada Burosumab Revenue Market Share by Type (2019-2030)
Figure 37. US & Canada Burosumab Sales Market Share by Application (2019-2030)
Figure 38. US & Canada Burosumab Revenue Market Share by Application (2019-2030)
Figure 39. US & Canada Burosumab Revenue Share by Country (2019-2030)
Figure 40. US & Canada Burosumab Sales Share by Country (2019-2030)
Figure 41. U.S. Burosumab Revenue (2019-2030) & (US$ Million)
Figure 42. Canada Burosumab Revenue (2019-2030) & (US$ Million)
Figure 43. Europe Burosumab Sales Market Share by Type (2019-2030)
Figure 44. Europe Burosumab Revenue Market Share by Type (2019-2030)
Figure 45. Europe Burosumab Sales Market Share by Application (2019-2030)
Figure 46. Europe Burosumab Revenue Market Share by Application (2019-2030)
Figure 47. Europe Burosumab Revenue Share by Country (2019-2030)
Figure 48. Europe Burosumab Sales Share by Country (2019-2030)
Figure 49. Germany Burosumab Revenue (2019-2030) & (US$ Million)
Figure 50. France Burosumab Revenue (2019-2030) & (US$ Million)
Figure 51. U.K. Burosumab Revenue (2019-2030) & (US$ Million)
Figure 52. Italy Burosumab Revenue (2019-2030) & (US$ Million)
Figure 53. Russia Burosumab Revenue (2019-2030) & (US$ Million)
Figure 54. China Burosumab Sales Market Share by Type (2019-2030)
Figure 55. China Burosumab Revenue Market Share by Type (2019-2030)
Figure 56. China Burosumab Sales Market Share by Application (2019-2030)
Figure 57. China Burosumab Revenue Market Share by Application (2019-2030)
Figure 58. Asia Burosumab Sales Market Share by Type (2019-2030)
Figure 59. Asia Burosumab Revenue Market Share by Type (2019-2030)
Figure 60. Asia Burosumab Sales Market Share by Application (2019-2030)
Figure 61. Asia Burosumab Revenue Market Share by Application (2019-2030)
Figure 62. Asia Burosumab Revenue Share by Region (2019-2030)
Figure 63. Asia Burosumab Sales Share by Region (2019-2030)
Figure 64. Japan Burosumab Revenue (2019-2030) & (US$ Million)
Figure 65. South Korea Burosumab Revenue (2019-2030) & (US$ Million)
Figure 66. China Taiwan Burosumab Revenue (2019-2030) & (US$ Million)
Figure 67. Southeast Asia Burosumab Revenue (2019-2030) & (US$ Million)
Figure 68. India Burosumab Revenue (2019-2030) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Burosumab Sales Market Share by Type (2019-2030)
Figure 70. Middle East, Africa and Latin America Burosumab Revenue Market Share by Type (2019-2030)
Figure 71. Middle East, Africa and Latin America Burosumab Sales Market Share by Application (2019-2030)
Figure 72. Middle East, Africa and Latin America Burosumab Revenue Market Share by Application (2019-2030)
Figure 73. Middle East, Africa and Latin America Burosumab Revenue Share by Country (2019-2030)
Figure 74. Middle East, Africa and Latin America Burosumab Sales Share by Country (2019-2030)
Figure 75. Brazil Burosumab Revenue (2019-2030) & (US$ Million)
Figure 76. Mexico Burosumab Revenue (2019-2030) & (US$ Million)
Figure 77. Turkey Burosumab Revenue (2019-2030) & (US$ Million)
Figure 78. Israel Burosumab Revenue (2019-2030) & (US$ Million)
Figure 79. GCC Countries Burosumab Revenue (2019-2030) & (US$ Million)
Figure 80. Burosumab Value Chain
Figure 81. Burosumab Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed
